Hydrogenetics, Inc.
Hydrogenetics, Inc.
Your view on HYGN
Overview
What the company does, where it operates, and who runs it.
About Hydrogenetics, Inc.
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
- CEO
- Charles W. Hansen III
- Headquarters
- 1451 Cypress Creek Road, Fort Lauderdale, US
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
- CEO
- Charles W. Hansen III
- Headquarters
- 1451 Cypress Creek Road, Fort Lauderdale, US
Hydrogenetics, Inc., through its subsidiary, HydroAxis Technologies, Inc., develops a hydrogen generating system to be used as a complete device for gas and diesel internal combustion engine in various markets worldwide, such as automotive, truck, marine, farm tractors, earth moving vehicles, military, locomotive engines, mining, home heating units, generators, recreation vehicles, fork trucks, and lawn mowers using diesel or gas engines.
It also owns Pacific Lights Entertainment, Inc., a film production company that produces small budget films in the comedy and Sci-Fi genres.
The company, through its other subsidiary, Buffalo Biodiesel Inc., collects and sources waste vegetable oil from commercial food preparation establishments, and reselling it as raw feedstock to bio-diesel refineries; and sells bio-diesel and yellow grease for the production of bio-diesel to companies in the United States and internationally.
The company was formerly known as Global Entertainment Acquisition Corp. and changed its name to Hydrogenetics, Inc. in August 2008. The company was incorporated in 1996 and is based in Fort Lauderdale, Florida.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for Hydrogenetics, Inc. from FRC's valuation model, read against the market price. HYGN last traded at $0.0001; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Hydrogenetics, Inc.. Starting points for Hydrogenetics, Inc.: beta -42.99 — an Chemicals - Specialty name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Hydrogenetics, Inc.. Hydrogenetics, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Hydrogenetics, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Hydrogenetics, Inc.. Hydrogenetics, Inc. has reported as a listed company since 2006. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Hydrogenetics, Inc. valued side by side against its closest peers. Hydrogenetics, Inc. is measured against Chemicals - Specialty peers within the Basic Materials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Hydrogenetics, Inc., and how their positions are changing. At a $36,326 market value, institutional positions materially move Hydrogenetics, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Hydrogenetics, Inc. executives and directors. Shares of Hydrogenetics, Inc. have traded between $0.0000 and $0.0002 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Hydrogenetics, Inc.. Hydrogenetics, Inc. is a $36,326 Basic Materials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Hydrogenetics, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Hydrogenetics, Inc.. Coverage tracks Hydrogenetics, Inc. within Chemicals - Specialty (Basic Materials). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Hydrogenetics, Inc.